EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
24 hedge funds and large institutions have $33.9M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
62% less capital invested
Capital invested by funds: $89.7M → $33.9M (-$55.9M)
Holders
24
Holding in Top 10
4
Calls
$142K
Puts
–
Top Buyers
| 1 | +$2.46M | |
| 2 | +$1.28M | |
| 3 | +$72.6K | |
| 4 |
Renaissance Technologies
New York
|
+$70.9K |
| 5 |
CC
Callan Capital
La Jolla,
California
|
+$48.4K |